<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41-pharmaceuticals-12-00157">
 <label>41.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Balasubramanian</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Teramoto</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kulkarni</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Bhattacharjee</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Padmanabhan</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus</article-title>
  <source>Antivir. Res.</source>
  <year>2017</year>
  <volume>137</volume>
  <fpage>141</fpage>
  <lpage>150</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2016.11.015</pub-id>
  <?supplied-pmid 27889529?>
  <pub-id pub-id-type="pmid">27889529</pub-id>
 </element-citation>
</ref>
